阿美瑞斯科
AMRC
19.50
-0.59
-2.94%
阿美瑞斯科
US · AMRC
#3147 按市值排名
19.50
-0.59
-2.94%
实时 - 追踪5344个代码 - 心跳于403秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 70.56% -0.04pp
- 机构数量
- 245
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund56.42%
Individual/Insider39.62%
Hedge Fund10.44%
Public Company1.83%
Private Company1.24%
Government Pension Fund0.26%
Insurance Company0.15%
Sovereign Wealth Fund0.14%
主要股东 截至 2026-09-10
George Sakellaris
38.29% · 20.32M 股
Wellington Management Group
6.36% · 3.37M 股
BlackRock
5.00% · 2.65M 股
Grantham Mayo Van Otterloo & Co. LLC
3.83% · 2.03M 股
Millennium Management LLC
3.42% · 1.82M 股
Vanguard Capital Management, LLC
3.08% · 1.64M 股
Dimensional Fund Advisors
3.02% · 1.60M 股
State Street Global Advisors
3.02% · 1.60M 股
D. E. Shaw & Co., L.P.
2.37% · 1.26M 股
DNB Asset Management AS
1.93% · 1.03M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 34次买入 · 9次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| George Sakellaris | Chairperson & CEO | 38.29% |
| Joseph Sutton | Lead Independent Director | 0.15% |
| Nicole Bulgarino | Executive VP & GM of Federal Solutions | 0.12% |
| Brian Cox | Director | 0.08% |
| Francis Wisneski | Independent Director | 0.07% |
| Jennifer Miller | Independent Director | 0.07% |
| Louis Maltezos | Executive Vice President of Central Region & Canada Operations | 0.06% |
| Nickolas Stavropoulos | Independent Director | 0.05% |
| Charles Patton | Independent Director | 0.04% |
| Claire D'Oyly-Hughes Johnson | Independent Director | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-24 | Julie Bradshaw | Interim Principal Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-09-24 | Debbie Angelico | Interim Principal Accounting Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-09-14 | Louis Maltezos | Executive Vice President of Central Region & Canada Operations | Open Market Disposition | -592 | $22.46 |
| 2026-09-14 | Mark Chiplock | Senior VP of Finance & Chief Accounting Officer | Open Market Disposition | -476 | $22.46 |
| 2026-09-09 | George Sakellaris | Chairperson & CEO | Derivative Exercise and Retained | +6,250 | -- |
| 2026-09-09 | Louis Maltezos | Executive Vice President of Central Region & Canada Operations | Derivative Exercise and Retained | +2,125 | -- |
| 2026-09-09 | Nicole Bulgarino | Executive VP & GM of Federal Solutions | Derivative Exercise and Retained | +1,875 | -- |
| 2026-09-09 | Mark Chiplock | Senior VP of Finance & Chief Accounting Officer | Derivative Exercise and Retained | +1,625 | -- |
| 2026-09-09 | Peter Christakis | Executive VP & GM of Northeast Region | Derivative Exercise and Retained | +1,750 | -- |
| 2026-08-27 | George Sakellaris | Chairperson & CEO | Open Market Acquisition | +3,000 | $22.13 |
| 2026-08-26 | George Sakellaris | Chairperson & CEO | Open Market Acquisition | +5,000 | $21.92–22.84 |
| 2026-08-24 | George Sakellaris | Chairperson & CEO | Open Market Acquisition | +10,000 | $20.91–22.03 |
| 2026-08-23 | Joseph Sutton | Lead Independent Director | Open Market Acquisition | +9,700 | $20.87 |
| 2026-08-23 | Jennifer Miller | Independent Director | Open Market Acquisition | +2,000 | $20.96 |
| 2026-08-20 | Brian Cox | Director | Open Market Acquisition | +4,625 | $21.64 |
| 2026-08-16 | David Corrsin | Executive VP, General Counsel, Corporate Secretary & Director | Other Derivative Acquisition | +25,000 | $14.55 |
| 2026-08-10 | George Sakellaris | Chairperson & CEO | Open Market Acquisition | +7,000 | $25.27–25.95 |
| 2026-08-09 | Brian Cox | Director | Open Market Acquisition | +39,700 | $25.07 |
| 2026-07-31 | Brian Cox | Director | Other Derivative Acquisition | +5,132 | -- |
| 2026-06-03 | Joseph Sutton | Lead Independent Director | Other Derivative Acquisition | +4,812 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:22 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
阿美瑞斯科 讨论区 0 条评论